Delivery Order SPE2DB25D3022-SPE2DB25FWBZN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,958.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was awarded without set-aside designations through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside, firm fixed-price delivery order represents a competitively awarded contract for pharmaceutical supplies to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 7, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,377.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 25, 2025, with completion targeted for July 28, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a firm fixed price delivery order with no set-aside designation, awarded competitively as part of the company's broader pharmaceutical supply relationship with the federal government. This...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12,000 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 21, 2025, with completion expected by July 22, 2025. This is a firm fixed price contract with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens totaling $3,303.30. This contract, which was awarded on June 3, 2025, with completion targeted for June 4, 2025, was executed under firm fixed-price terms with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,184.18, with completion scheduled for August 12, 2025. This competitive award, issued without set-aside provisions, represents a firm fixed-price delivery order for the diabetes medication to support federal healthcare requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens. This competitively awarded, firm fixed price delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order reflects the company's continued capability to compete...
- The Defense Logistics Agency awarded a $7,706.92 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 16, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,922.59 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a small-value delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be supplied from the...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBZNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,296.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. The parent contract demonstrates the company's critical role in supporting the Defense Health Agency and other federal healthcare systems through flexible procurement arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/21/25 |